D. Lowne

Isolation of Potent CGRP Neutralizing Antibodies Using Four Simple Assays

R. Howes, T. Wilkinson, T. Vaughan, 2016, Journal of biomolecular screening.

Combinatorial Screening Identifies Novel Promiscuous Matrix Metalloproteinase Activities that Lead to Inhibition of the Therapeutic Target IL-13.

F. Hollfelder, R. Minter, N. Gordon, 2015, Chemistry & biology.

Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine

I. Chessell, D. Dodick, E. Navratilova, 2020, Cephalalgia : an international journal of headache.

Chemical modification of a variant of human MIP-1alpha; implications for dimer structure.

J. Arnold, L. Czaplewski, P. Varley, 2000, Protein science : a publication of the Protein Society.

Combining phenotypic and proteomic approaches to identify membrane targets in a ‘triple negative’ breast cancer cell type

R. Minter, L. Jermutus, A. Karlsson, 2013, Molecular Cancer.

Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo

S. Radford, N. Ranson, C. F. van der Walle, 2016, Scientific Reports.

Probing a protein–protein interaction by in vitro evolution

R. Minter, L. Jermutus, E. S. Cohen, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Affinity maturation of phage display antibody populations using ribosome display.

M. Groves, D. G. Rees, Steven Lane, 2006, Journal of immunological methods.

For the record: Chemical modification of a variant of human MIP‐1α; implications for dimer structure

J. Arnold, L. Czaplewski, P. Varley, 2000 .